Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 500 entries
Sorted by: Best Match Show Resources per page
High baseline levels of interleukin-8 in leukocytes and urine predict tumor recurrence in non-muscle invasive bladder cancer patients receiving bacillus Calmette-Guerin therapy: A long-term survival analysis.

Oncoimmunology

Qu K, Gu J, Ye Y, Williams SB, Dinney CP, Wu X, Kamat A.
PMID: 28344874
Oncoimmunology. 2017 Jan 03;6(2):e1265719. doi: 10.1080/2162402X.2016.1265719. eCollection 2017.

Bacillus Calmette-Guerin (BCG) therapy for non-muscle invasive bladder cancer (NMIBC) can significantly reduce the risk of recurrence and progression. However, BCG therapy may fail in up to a half of treated patients and may also cause toxicities. Biomarkers to...

Cite
Qu K, Gu J, Ye Y, et al. High baseline levels of interleukin-8 in leukocytes and urine predict tumor recurrence in non-muscle invasive bladder cancer patients receiving bacillus Calmette-Guerin therapy: A long-term survival analysis. Oncoimmunology. 2017;6(2):e1265719doi: 10.1080/2162402X.2016.1265719.
Qu, K., Gu, J., Ye, Y., Williams, S. B., Dinney, C. P., Wu, X., & Kamat, A. (2017). High baseline levels of interleukin-8 in leukocytes and urine predict tumor recurrence in non-muscle invasive bladder cancer patients receiving bacillus Calmette-Guerin therapy: A long-term survival analysis. Oncoimmunology, 6(2), e1265719. https://doi.org/10.1080/2162402X.2016.1265719
Qu, Kai, et al. "High baseline levels of interleukin-8 in leukocytes and urine predict tumor recurrence in non-muscle invasive bladder cancer patients receiving bacillus Calmette-Guerin therapy: A long-term survival analysis." Oncoimmunology vol. 6,2 (2017): e1265719. doi: https://doi.org/10.1080/2162402X.2016.1265719
Qu K, Gu J, Ye Y, Williams SB, Dinney CP, Wu X, Kamat A. High baseline levels of interleukin-8 in leukocytes and urine predict tumor recurrence in non-muscle invasive bladder cancer patients receiving bacillus Calmette-Guerin therapy: A long-term survival analysis. Oncoimmunology. 2017 Jan 03;6(2):e1265719. doi: 10.1080/2162402X.2016.1265719. eCollection 2017. PMID: 28344874; PMCID: PMC5353920.
Copy Download .nbib Format: NLM
[Not Available].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie

Seisen T, Granger B, Colin P, Léon P, Utard G, Renard Penna R, Compérat E, Mozer P, Cussenot O, Shariat S, Rouprêt M.
PMID: 26544373
Prog Urol. 2015 Nov;25(13):805. doi: 10.1016/j.purol.2015.08.178.

No abstract available.

Cite
Seisen T, Granger B, Colin P, et al. Revue systématique de la littérature et méta-analyse des facteurs de risque de récidive vésicale après néphro-uréterectomie totale pour le traitement d'une tumeur de la voie excrétrice urinaire supérieure. [Not Available]. Prog Urol. 2015;25(13):805doi: 10.1016/j.purol.2015.08.178.
Seisen, T., Granger, B., Colin, P., Léon, P., Utard, G., Renard Penna, R., Compérat, E., Mozer, P., Cussenot, O., Shariat, S., & Rouprêt, M. (2015). Revue systématique de la littérature et méta-analyse des facteurs de risque de récidive vésicale après néphro-uréterectomie totale pour le traitement d'une tumeur de la voie excrétrice urinaire supérieure. [Not Available]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 25(13), 805. https://doi.org/10.1016/j.purol.2015.08.178
Seisen, T, et al. "Revue systématique de la littérature et méta-analyse des facteurs de risque de récidive vésicale après néphro-uréterectomie totale pour le traitement d'une tumeur de la voie excrétrice urinaire supérieure." [Not Available]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie vol. 25,13 (2015): 805. doi: https://doi.org/10.1016/j.purol.2015.08.178
Seisen T, Granger B, Colin P, Léon P, Utard G, Renard Penna R, Compérat E, Mozer P, Cussenot O, Shariat S, Rouprêt M. Revue systématique de la littérature et méta-analyse des facteurs de risque de récidive vésicale après néphro-uréterectomie totale pour le traitement d'une tumeur de la voie excrétrice urinaire supérieure. [Not Available]. Prog Urol. 2015 Nov;25(13):805. doi: 10.1016/j.purol.2015.08.178. French. PMID: 26544373.
Copy Download .nbib Format: NLM
[Not Available].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie

Seisen T, Compérat E, Colin P, Peyronnet B, Bensalah K, Rioux-Leclerc N, Xylinas E, Bigot P, Pfister C, Long J, Irani J, Guy L, Neuzillet Y, Droupy S, De la Taille A, Cussenot O, Bitker M, Rouprêt M.
PMID: 26544374
Prog Urol. 2015 Nov;25(13):805-6. doi: 10.1016/j.purol.2015.08.179.

No abstract available.

Cite
Seisen T, Compérat E, Colin P, et al. Valeur pronostique de la sous-classification pT3 des tumeurs de la voie excrétrice urinaire supérieure localisées dans les cavités pyélocalicielles. [Not Available]. Prog Urol. 2015;25(13):805-6doi: 10.1016/j.purol.2015.08.179.
Seisen, T., Compérat, E., Colin, P., Peyronnet, B., Bensalah, K., Rioux-Leclerc, N., Xylinas, E., Bigot, P., Pfister, C., Long, J., Irani, J., Guy, L., Neuzillet, Y., Droupy, S., De la Taille, A., Cussenot, O., Bitker, M., & Rouprêt, M. (2015). Valeur pronostique de la sous-classification pT3 des tumeurs de la voie excrétrice urinaire supérieure localisées dans les cavités pyélocalicielles. [Not Available]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 25(13), 805-6. https://doi.org/10.1016/j.purol.2015.08.179
Seisen, T, et al. "Valeur pronostique de la sous-classification pT3 des tumeurs de la voie excrétrice urinaire supérieure localisées dans les cavités pyélocalicielles." [Not Available]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie vol. 25,13 (2015): 805-6. doi: https://doi.org/10.1016/j.purol.2015.08.179
Seisen T, Compérat E, Colin P, Peyronnet B, Bensalah K, Rioux-Leclerc N, Xylinas E, Bigot P, Pfister C, Long J, Irani J, Guy L, Neuzillet Y, Droupy S, De la Taille A, Cussenot O, Bitker M, Rouprêt M. Valeur pronostique de la sous-classification pT3 des tumeurs de la voie excrétrice urinaire supérieure localisées dans les cavités pyélocalicielles. [Not Available]. Prog Urol. 2015 Nov;25(13):805-6. doi: 10.1016/j.purol.2015.08.179. French. PMID: 26544374.
Copy Download .nbib Format: NLM
[Not Available].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie

Nison L, Colin P, Remzi M, Shariat S, Klatte T, Yakoubi R, Bozzini G, Capitanio U, Babjuk M, Merseburger A, Cha E, Fritsche H, Novara G, Montorsi F, Hora M, Roupret M.
PMID: 26544377
Prog Urol. 2015 Nov;25(13):807. doi: 10.1016/j.purol.2015.08.182.

No abstract available.

Cite
Nison L, Colin P, Remzi M, et al. Résultats oncologiques du traitement des TVES≤pT2 de l'uretère pelvien par néphro-urétérectomie, résection segmentaire et chirurgie endoscopique : résultats d'une étude multicentrique européenne. [Not Available]. Prog Urol. 2015;25(13):807doi: 10.1016/j.purol.2015.08.182.
Nison, L., Colin, P., Remzi, M., Shariat, S., Klatte, T., Yakoubi, R., Bozzini, G., Capitanio, U., Babjuk, M., Merseburger, A., Cha, E., Fritsche, H., Novara, G., Montorsi, F., Hora, M., & Roupret, M. (2015). Résultats oncologiques du traitement des TVES≤pT2 de l'uretère pelvien par néphro-urétérectomie, résection segmentaire et chirurgie endoscopique : résultats d'une étude multicentrique européenne. [Not Available]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 25(13), 807. https://doi.org/10.1016/j.purol.2015.08.182
Nison, L, et al. "Résultats oncologiques du traitement des TVES≤pT2 de l'uretère pelvien par néphro-urétérectomie, résection segmentaire et chirurgie endoscopique : résultats d'une étude multicentrique européenne." [Not Available]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie vol. 25,13 (2015): 807. doi: https://doi.org/10.1016/j.purol.2015.08.182
Nison L, Colin P, Remzi M, Shariat S, Klatte T, Yakoubi R, Bozzini G, Capitanio U, Babjuk M, Merseburger A, Cha E, Fritsche H, Novara G, Montorsi F, Hora M, Roupret M. Résultats oncologiques du traitement des TVES≤pT2 de l'uretère pelvien par néphro-urétérectomie, résection segmentaire et chirurgie endoscopique : résultats d'une étude multicentrique européenne. [Not Available]. Prog Urol. 2015 Nov;25(13):807. doi: 10.1016/j.purol.2015.08.182. French. PMID: 26544377.
Copy Download .nbib Format: NLM
Structural studies of 1,1-dimethyl-2-oxy-1-silacyclohexane by means of matrix isolation infrared absorption spectroscopy.

The journal of physical chemistry. A

Ceponkus J, Jonusas M, Cotter CP, Pucetaite M, Aleksa V, Guirgis GA, Sablinskas V.
PMID: 25513738
J Phys Chem A. 2015 Mar 19;119(11):2721-6. doi: 10.1021/jp5099014. Epub 2014 Dec 30.

Infrared spectra of gaseous, liquid, and matrix-isolated samples of newly synthesized 1,1-dimethyl-2-oxy-1-silacyclohexane were recorded. Raman spectra of 1,1-dimethyl-2-oxy-1-silacyclohexane in liquid and solid states were obtained in the temperature range from 170 to 340 K. Ab initio HF and DFT...

Cite
Ceponkus J, Jonusas M, Cotter CP, et al. Structural studies of 1,1-dimethyl-2-oxy-1-silacyclohexane by means of matrix isolation infrared absorption spectroscopy. J Phys Chem A. 2014;119(11):2721-6doi: 10.1021/jp5099014.
Ceponkus, J., Jonusas, M., Cotter, C. P., Pucetaite, M., Aleksa, V., Guirgis, G. A., & Sablinskas, V. (2015). Structural studies of 1,1-dimethyl-2-oxy-1-silacyclohexane by means of matrix isolation infrared absorption spectroscopy. The journal of physical chemistry. A, 119(11), 2721-6. https://doi.org/10.1021/jp5099014
Ceponkus, Justinas, et al. "Structural studies of 1,1-dimethyl-2-oxy-1-silacyclohexane by means of matrix isolation infrared absorption spectroscopy." The journal of physical chemistry. A vol. 119,11 (2015): 2721-6. doi: https://doi.org/10.1021/jp5099014
Ceponkus J, Jonusas M, Cotter CP, Pucetaite M, Aleksa V, Guirgis GA, Sablinskas V. Structural studies of 1,1-dimethyl-2-oxy-1-silacyclohexane by means of matrix isolation infrared absorption spectroscopy. J Phys Chem A. 2015 Mar 19;119(11):2721-6. doi: 10.1021/jp5099014. Epub 2014 Dec 30. PMID: 25513738.
Copy Download .nbib Format: NLM
COPD: adherence to therapy.

Multidisciplinary respiratory medicine

Sanduzzi A, Balbo P, Candoli P, Catapano GA, Contini P, Mattei A, Puglisi G, Santoiemma L, Stanziola AA.
PMID: 25485108
Multidiscip Respir Med. 2014 Nov 22;9(1):60. doi: 10.1186/2049-6958-9-60. eCollection 2014.

Adherence to medical therapies is a growing issue, so much so that the World Health Organization defined it as "a new pharmacological problem". The main factors affecting compliance are: frequency of administration, rapid onset of action, role of device....

Cite
Sanduzzi A, Balbo P, Candoli P, et al. COPD: adherence to therapy. Multidiscip Respir Med. 2014;9(1):60doi: 10.1186/2049-6958-9-60.
Sanduzzi, A., Balbo, P., Candoli, P., Catapano, G. A., Contini, P., Mattei, A., Puglisi, G., Santoiemma, L., & Stanziola, A. A. (2014). COPD: adherence to therapy. Multidisciplinary respiratory medicine, 9(1), 60. https://doi.org/10.1186/2049-6958-9-60
Sanduzzi, Alessandro, et al. "COPD: adherence to therapy." Multidisciplinary respiratory medicine vol. 9,1 (2014): 60. doi: https://doi.org/10.1186/2049-6958-9-60
Sanduzzi A, Balbo P, Candoli P, Catapano GA, Contini P, Mattei A, Puglisi G, Santoiemma L, Stanziola AA. COPD: adherence to therapy. Multidiscip Respir Med. 2014 Nov 22;9(1):60. doi: 10.1186/2049-6958-9-60. eCollection 2014. PMID: 25485108; PMCID: PMC4256899.
Copy Download .nbib Format: NLM
Relating annual increments of the endangered Blanding's turtle plastron growth to climate.

Ecology and evolution

Richard MG, Laroque CP, Herman TB.
PMID: 24963390
Ecol Evol. 2014 May;4(10):1972-80. doi: 10.1002/ece3.1065. Epub 2014 Apr 22.

This research is the first published study to report a relationship between climate variables and plastron growth increments of turtles, in this case the endangered Nova Scotia Blanding's turtle (Emydoidea blandingii). We used techniques and software common to the...

Cite
Richard MG, Laroque CP, Herman TB. Relating annual increments of the endangered Blanding's turtle plastron growth to climate. Ecol Evol. 2014;4(10):1972-80doi: 10.1002/ece3.1065.
Richard, M. G., Laroque, C. P., & Herman, T. B. (2014). Relating annual increments of the endangered Blanding's turtle plastron growth to climate. Ecology and evolution, 4(10), 1972-80. https://doi.org/10.1002/ece3.1065
Richard, Monik G, et al. "Relating annual increments of the endangered Blanding's turtle plastron growth to climate." Ecology and evolution vol. 4,10 (2014): 1972-80. doi: https://doi.org/10.1002/ece3.1065
Richard MG, Laroque CP, Herman TB. Relating annual increments of the endangered Blanding's turtle plastron growth to climate. Ecol Evol. 2014 May;4(10):1972-80. doi: 10.1002/ece3.1065. Epub 2014 Apr 22. PMID: 24963390; PMCID: PMC4063489.
Copy Download .nbib Format: NLM
Differences in GPR30 Regulation by Chlorotriazine Herbicides in Human Breast Cells.

Biochemistry research international

Florian CP, Mansfield SR, Schroeder JR.
PMID: 26955487
Biochem Res Int. 2016;2016:2984081. doi: 10.1155/2016/2984081. Epub 2016 Feb 03.

Over 200,000 cases of invasive breast cancer are diagnosed annually; herbicide contaminants in local water sources may contribute to the growth of these cancers. GPR30, a G protein coupled receptor, was identified as a potential orphan receptor that may...

Cite
Florian CP, Mansfield SR, Schroeder JR. Differences in GPR30 Regulation by Chlorotriazine Herbicides in Human Breast Cells. Biochem Res Int. 2016;2016:2984081doi: 10.1155/2016/2984081.
Florian, C. P., Mansfield, S. R., & Schroeder, J. R. (2016). Differences in GPR30 Regulation by Chlorotriazine Herbicides in Human Breast Cells. Biochemistry research international, 20162984081. https://doi.org/10.1155/2016/2984081
Florian, Colin P, et al. "Differences in GPR30 Regulation by Chlorotriazine Herbicides in Human Breast Cells." Biochemistry research international vol. 2016 (2016): 2984081. doi: https://doi.org/10.1155/2016/2984081
Florian CP, Mansfield SR, Schroeder JR. Differences in GPR30 Regulation by Chlorotriazine Herbicides in Human Breast Cells. Biochem Res Int. 2016;2016:2984081. doi: 10.1155/2016/2984081. Epub 2016 Feb 03. PMID: 26955487; PMCID: PMC4756223.
Copy Download .nbib Format: NLM
Quantitative assessment of placental morphology may identify specific causes of stillbirth.

BMC clinical pathology

Ptacek I, Smith A, Garrod A, Bullough S, Bradley N, Batra G, Sibley CP, Jones RL, Brownbill P, Heazell AE.
PMID: 26865834
BMC Clin Pathol. 2016 Feb 09;16:1. doi: 10.1186/s12907-016-0023-y. eCollection 2016.

BACKGROUND: Stillbirth is frequently the result of pathological processes involving the placenta. Understanding the significance of specific lesions is hindered by qualitative subjective evaluation. We hypothesised that quantitative assessment of placental morphology would identify alterations between different causes of...

Cite
Ptacek I, Smith A, Garrod A, et al. Quantitative assessment of placental morphology may identify specific causes of stillbirth. BMC Clin Pathol. 2016;16:1doi: 10.1186/s12907-016-0023-y.
Ptacek, I., Smith, A., Garrod, A., Bullough, S., Bradley, N., Batra, G., Sibley, C. P., Jones, R. L., Brownbill, P., & Heazell, A. E. (2016). Quantitative assessment of placental morphology may identify specific causes of stillbirth. BMC clinical pathology, 161. https://doi.org/10.1186/s12907-016-0023-y
Ptacek, Imogen, et al. "Quantitative assessment of placental morphology may identify specific causes of stillbirth." BMC clinical pathology vol. 16 (2016): 1. doi: https://doi.org/10.1186/s12907-016-0023-y
Ptacek I, Smith A, Garrod A, Bullough S, Bradley N, Batra G, Sibley CP, Jones RL, Brownbill P, Heazell AE. Quantitative assessment of placental morphology may identify specific causes of stillbirth. BMC Clin Pathol. 2016 Feb 09;16:1. doi: 10.1186/s12907-016-0023-y. eCollection 2016. PMID: 26865834; PMCID: PMC4748636.
Copy Download .nbib Format: NLM
Role of Health Services Research in Radiology.

Academic radiology

Rawson JV, Cronin P.
PMID: 28363671
Acad Radiol. 2017 May;24(5):519-520. doi: 10.1016/j.acra.2017.02.003. Epub 2017 Mar 28.

No abstract available.

Cite
Rawson JV, Cronin P. Role of Health Services Research in Radiology. Acad Radiol. 2017;24(5):519-520doi: 10.1016/j.acra.2017.02.003.
Rawson, J. V., & Cronin, P. (2017). Role of Health Services Research in Radiology. Academic radiology, 24(5), 519-520. https://doi.org/10.1016/j.acra.2017.02.003
Rawson, James V, and Cronin, Paul. "Role of Health Services Research in Radiology." Academic radiology vol. 24,5 (2017): 519-520. doi: https://doi.org/10.1016/j.acra.2017.02.003
Rawson JV, Cronin P. Role of Health Services Research in Radiology. Acad Radiol. 2017 May;24(5):519-520. doi: 10.1016/j.acra.2017.02.003. Epub 2017 Mar 28. PMID: 28363671.
Copy Download .nbib Format: NLM
Improving medication management for patients with multimorbidity in primary care: a qualitative feasibility study of the MY COMRADE implementation intervention.

Pilot and feasibility studies

Sinnott C, Byrne M, Bradley CP.
PMID: 28331631
Pilot Feasibility Stud. 2017 Mar 20;3:14. doi: 10.1186/s40814-017-0129-8. eCollection 2017.

BACKGROUND: For the majority of patients with multimorbidity, the prescription of multiple long-term medications (polypharmacy) is indicated. However, polypharmacy poses a risk of adverse drug events, drug interactions and excessive treatment burdens. To help general practitioners (GPs) conduct more...

Cite
Sinnott C, Byrne M, Bradley CP. Improving medication management for patients with multimorbidity in primary care: a qualitative feasibility study of the MY COMRADE implementation intervention. Pilot Feasibility Stud. 2017;3:14doi: 10.1186/s40814-017-0129-8.
Sinnott, C., Byrne, M., & Bradley, C. P. (2017). Improving medication management for patients with multimorbidity in primary care: a qualitative feasibility study of the MY COMRADE implementation intervention. Pilot and feasibility studies, 314. https://doi.org/10.1186/s40814-017-0129-8
Sinnott, Carol, et al. "Improving medication management for patients with multimorbidity in primary care: a qualitative feasibility study of the MY COMRADE implementation intervention." Pilot and feasibility studies vol. 3 (2017): 14. doi: https://doi.org/10.1186/s40814-017-0129-8
Sinnott C, Byrne M, Bradley CP. Improving medication management for patients with multimorbidity in primary care: a qualitative feasibility study of the MY COMRADE implementation intervention. Pilot Feasibility Stud. 2017 Mar 20;3:14. doi: 10.1186/s40814-017-0129-8. eCollection 2017. PMID: 28331631; PMCID: PMC5357807.
Copy Download .nbib Format: NLM
Transrectal Ultrasound Guided Biopsy of the Prostate: Is the Information Accessible, Usable, Reliable and Readable?.

Current urology

Redmond CE, Nason GJ, Kelly ME, McMahon C, Cantwell CP, Quinlan DM.
PMID: 26195961
Curr Urol. 2015 May;8(1):32-7. doi: 10.1159/000365686. Epub 2015 May 20.

BACKGROUND/AIMS: To evaluate the accessibility, usability, reliability and readability of Internet information regarding transrectal ultrasound (TRUS) guided biopsy of the prostate.MATERIALS AND METHODS: The terms "prostate biopsy", "TRUS biopsy" and "transrectal ultrasound guided biopsy of the prostate" were separately...

Cite
Redmond CE, Nason GJ, Kelly ME, et al. Transrectal Ultrasound Guided Biopsy of the Prostate: Is the Information Accessible, Usable, Reliable and Readable?. Curr Urol. 2015;8(1):32-7doi: 10.1159/000365686.
Redmond, C. E., Nason, G. J., Kelly, M. E., McMahon, C., Cantwell, C. P., & Quinlan, D. M. (2015). Transrectal Ultrasound Guided Biopsy of the Prostate: Is the Information Accessible, Usable, Reliable and Readable?. Current urology, 8(1), 32-7. https://doi.org/10.1159/000365686
Redmond, Ciaran E, et al. "Transrectal Ultrasound Guided Biopsy of the Prostate: Is the Information Accessible, Usable, Reliable and Readable?." Current urology vol. 8,1 (2015): 32-7. doi: https://doi.org/10.1159/000365686
Redmond CE, Nason GJ, Kelly ME, McMahon C, Cantwell CP, Quinlan DM. Transrectal Ultrasound Guided Biopsy of the Prostate: Is the Information Accessible, Usable, Reliable and Readable?. Curr Urol. 2015 May;8(1):32-7. doi: 10.1159/000365686. Epub 2015 May 20. PMID: 26195961; PMCID: PMC4483281.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 500 entries